Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUT8 | Q9BYC5 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 7/20 | 0.46 |
| ▸ | CA1 | P00915 | 7/20 | 0.46 |
| ▸ | CA2 | P00918 | 7/20 | 0.46 |
| ▸ | CA9 | Q16790 | 7/20 | 0.46 |
| ▸ | CHAT | P28329 | 3/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | APEX1 | P27695 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.42 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.41 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.41 |
| ▸ | SNCA | P37840 | 1/20 | 0.41 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13151833 | 0.90 | ALDH1A1 (0.46) | FUT8CHATALDH1A1HIF1AP2RX3 | |
| SCHEMBL10284775 | 0.87 | FUT8 (0.48) | FUT8CA12CA1CA2CA9 | |
| SCHEMBL13924366 | 0.85 | CTRB1 (0.46) | FUT8CA12CA1CA2CA9 | |
| SCHEMBL10284587 | 0.85 | CD40 (0.48) | FUT8CA12CA1CA2CA9 | |
| SCHEMBL14468813 | 0.84 | CA12 (0.57) | FUT8CA12CA1CA2CA9 | |
| SCHEMBL14600411 | 0.83 | FUT8 (0.45) | FUT8CA12CA1CA2CA9 | |
| SCHEMBL13800014 | 0.82 | CA12 (0.40) | FUT8CA12CA1CA2CA9 | |
| SCHEMBL12559088 | 0.81 | ENPP2 (0.47) | FUT8CHATALDH1A1HIF1ASNCA | |
| SCHEMBL13152017 | 0.81 | ENPP2 (0.53) | FUT8CA12CA1CA2CA9 | |
| SCHEMBL13924369 | 0.80 | HIF1A (0.55) | FUT8ALDH1A1HIF1ASNCAENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7799122-B2 | Azo compounds | FUJIFILM IMAGING COLORANTS LIMITED (GB) | 2010-09-21 | — | — | US | disclosed |
| US-7799122-B2 | Azo compounds | FUJIFILM IMAGING COLORANTS LIMITED (GB) | 2010-09-21 | — | — | US | disclosed |
| US-20100151212-A1 | Azo compounds | FUJIFILM IMAGING COLORANTS LIMITED (GB) | 2010-06-17 | — | — | US | disclosed |
| US-20100151212-A1 | Azo compounds | FUJIFILM IMAGING COLORANTS LIMITED (GB) | 2010-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100151212-A1 | Azo compounds | PAH, CYP1A1, RB1 | FUT8 3030/4885CA12 915/4885CA1 889/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.